Literature DB >> 20645874

Mechanisms of type III interferon expression.

Marie B Iversen1, Søren R Paludan.   

Abstract

Type III interferons (IFNs; IFN-lambda) are antiviral cytokines with type I IFN-like biological functions, including antiviral activity. In this article we review the literature on IFN-lambda expression and propose that important differences exist between the mechanisms governing expression of the different classes of IFNs. Importantly, while IFN-beta is induced by coordinated action of a multifactor enhanceosome, and IFN-alpha expression is activated by multiple IFN regulatory factor (IRF)-binding cis-promoter elements, the type III IFNs are induced through independent actions of IRFs and nuclear factor-kappaB. Although these differences may appear minor at first glance, we propose that IFN-lambda expression is more flexible than IFN-alpha/beta expression, which could allow expression of type III IFNs in response to a wider range of stimuli compared with type I IFNs. Moreover, such a mechanism of induction will potentially render expression of type III IFNs less sensitive to microbial evasion strategies targeting the IRF pathway. Thus, the mechanisms governing type III IFN expression play an important part in dictating the biology of this antiviral cytokine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645874     DOI: 10.1089/jir.2010.0063

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  42 in total

1.  Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Authors:  Eva Perez-Martin; Marcelo Weiss; Fayna Diaz-San Segundo; Juan M Pacheco; Jonathan Arzt; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  RIG-I activation inhibits HIV replication in macrophages.

Authors:  Yizhong Wang; Xu Wang; Jieliang Li; Yu Zhou; Wenzhe Ho
Journal:  J Leukoc Biol       Date:  2013-06-06       Impact factor: 4.962

4.  NK cells require IL-28R for optimal in vivo activity.

Authors:  Fernando Souza-Fonseca-Guimaraes; Arabella Young; Deepak Mittal; Ludovic Martinet; Claudia Bruedigam; Kazuyoshi Takeda; Christopher E Andoniou; Mariapia A Degli-Esposti; Geoffrey R Hill; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-21       Impact factor: 11.205

5.  Functional characterization of canine interferon-lambda.

Authors:  Wenhui Fan; Lei Xu; Liqian Ren; Hongren Qu; Jing Li; Jingjing Liang; Wenjun Liu; Limin Yang; Tingrong Luo
Journal:  J Interferon Cytokine Res       Date:  2014-06-20       Impact factor: 2.607

Review 6.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

7.  IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

Authors:  Heiyoung Park; Elisavet Serti; Onyinyechi Eke; Brian Muchmore; Ludmila Prokunina-Olsson; Stefania Capone; Antonella Folgori; Barbara Rehermann
Journal:  Hepatology       Date:  2012-11-19       Impact factor: 17.425

Review 8.  The role of airway epithelial cells and innate immune cells in chronic respiratory disease.

Authors:  Michael J Holtzman; Derek E Byers; Jennifer Alexander-Brett; Xinyu Wang
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

Review 9.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

10.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.